Saleh, Abdulrahman M., Mahdy, Hazem A., El-Zahabi, Mohamed Ayman, Mehany, Ahmed B. M., Khalifa, Mohamed M., Eissa, Ibrahim H. (2023) Design, synthesis, in silico studies, and biological evaluation of novel pyrimidine-5-carbonitrile derivatives as potential anti-proliferative agents, VEGFR-2 inhibitors and apoptotic inducers. RSC Advances, 13 (32) Royal Society of Chemistry (RSC) 22122-22147 doi:10.1039/d3ra04182d

See Also

These are possibly similar items as determined by title/reference text matching only.

	Eissa, Ibrahim H., Yousef, Reda G., Elkady, Hazem, Elkaeed, Eslam B., Alsfouk, Aisha A., Husein, Dalal Z., Ibrahim, Ibrahim M., Elhendawy, Mostafa A., Godfrey, Murrell, Metwaly, Ahmed M. (2023) Identification of new theobromine-based derivatives as potent VEGFR-2 inhibitors: design, semi-synthesis, biological evaluation, and in silico studies. RSC Advances, 13 (33) Royal Society of Chemistry (RSC) 23285-23307 doi:10.1039/d3ra04007k
	El-Metwally, Souad A., Elkady, Hazem, Hagras, Mohamed, Husein, Dalal Z., Ibrahim, Ibrahim M., Taghour, Mohammed S., El-Mahdy, Hesham A., Ismail, Ahmed, Alsfouk, Bshra A., Elkaeed, Eslam B., Metwaly, Ahmed M., Eissa, Ibrahim H. (2023) Design, synthesis, anti-proliferative evaluation, docking, and MD simulation studies of new thieno[2,3-d]pyrimidines targeting VEGFR-2. RSC Advances, 13 (33) 23365-23385 doi:10.1039/d3ra03128d
	Kotb, Anas Ramadan, Abdallah, Abdallah E., Elkady, Hazem, Eissa, Ibrahim H., Taghour, Mohammed S., Bakhotmah, Dina Abed, Abdelghany, Tamer M., El-Zahabi, Mohamed Ayman (2023) Design, synthesis, anticancer evaluation, and in silico ADMET analysis of novel thalidomide analogs as promising immunomodulatory agents. RSC Advances, 13 (16) 10488-10502 doi:10.1039/d3ra00066d
	Yousef, Reda G., Elwan, Alaa, Abdallah, Abdallah E., Elkady, Hazem, Mehany, Ahmed B.M., Abo-Saif, Mariam Ali, Radwan, Mohamed M., ElSohly, Mahmoud A., Ibrahim, Ibrahim M., Elkady, Mohamed A., El-Zahabi, Mohamed Ayman, Eissa, Ibrahim H. (2024) Biological and computational assessment of new synthesized nicotinamides as potential immunomodulatory VEGFR-2 inhibitors. Journal of Molecular Structure, 1305. 137753 doi:10.1016/j.molstruc.2024.137753
	Kotb, Anas Ramadan, Bakhotmah, Dina A., Abdallah, Abdallah E., Elkady, Hazem, Taghour, Mohammed S., Eissa, Ibrahim. H., El-Zahabi, Mohamed Ayman (2022) Design, synthesis, and biological evaluation of novel bioactive thalidomide analogs as anticancer immunomodulatory agents. RSC Advances, 12 (52) 33525-33539 doi:10.1039/d2ra06188k
	Elkady, Hazem, El-Dardir, Osama A., Elwan, Alaa, Taghour, Mohammed S., Mahdy, Hazem A., Dahab, Mohammed A., Elkaeed, Eslam B., Alsfouk, Bshra A., Ibrahim, Ibrahim M., Husein, Dalal Z., Hafez, Elsayed E., Darwish, Amira M. G., Metwaly, Ahmed M., Eissa, Ibrahim H. (2023) Synthesis, biological evaluation and computer-aided discovery of new thiazolidine-2,4-dione derivatives as potential antitumor VEGFR-2 inhibitors. RSC Advances, 13 (40) 27801-27827 doi:10.1039/d3ra05689a
	Yousef, Reda G., Sakr, Helmy M., Eissa, Ibrahim H., Mehany, Ahmed. B. M., Metwaly, Ahmed M., Elhendawy, Mostafa A., Radwan, Mohamed M., ElSohly, Mahmoud A., Abulkhair, Hamada S., El-Adl, Khaled. (2021) New quinoxaline-2(1H)-ones as potential VEGFR-2 inhibitors: design, synthesis, molecular docking, ADMET profile and anti-proliferative evaluations. New Journal of Chemistry, 45 (36) 16949-16964 doi:10.1039/d1nj02509k
	El-Metwally, Souad A., Omara, Mariam, Elkady, Hazem, Elkaeed, Eslam B., Al-ghulikah, Hanan A., Taghour, Mohammed S., El-Mahdy, Hesham A., Ibrahim, Ibrahim M., Husein, Dalal Z., Metwaly, Ahmed M., Eissa, Ibrahim H. (2024) New modified thieno[2,3-d]pyrimidine derivatives as VEGFR-2 inhibitors: Design, synthesis, in vitro anti-cancer evaluation and divers in silico studies. Journal of Molecular Structure, 1302. 137465 doi:10.1016/j.molstruc.2023.137465
	Hagras, Mohamed, Mandour, Asmaa A., Mohamed, Esraa A., Elkaeed, Eslam B., Gobaara, Ibrahim M. M., Mehany, Ahmed B. M., Ismail, Nasser S. M., Refaat, Hanan M. (2021) Design, synthesis, docking study and anticancer evaluation of new trimethoxyphenyl pyridine derivatives as tubulin inhibitors and apoptosis inducers. RSC Advances, 11 (63) 39728-39741 doi:10.1039/d1ra07922k
	Eissa, Ibrahim H., Yousef, Reda G., Elkady, Hazem, Elkaeed, Eslam B., Alsfouk, Aisha A., Husein, Dalal Z., Ibrahim, Ibrahim M., Elhendawy, Mostafa.A., Godfrey, Murrell, Metwaly, Ahmed M. (2023) Design, semi-synthesis, anti-cancer assessment, docking, MD simulation, and DFT studies of novel theobromine-based derivatives as VEGFR-2 inhibitors and apoptosis inducers. Computational Biology and Chemistry, 107. 107953 doi:10.1016/j.compbiolchem.2023.107953
	Raslan, Reham R., Ammar, Yousry A., Fouad, Sawsan A., Hessein, Sadia A., Shmiess, Nadia A. M., Ragab, Ahmed (2023) Evaluation of the anti-proliferative activity of 2-oxo-pyridine and 1′H-spiro-pyridine derivatives as a new class of EGFRWt and VEGFR-2 inhibitors with apoptotic inducers. RSC Advances, 13 (15) 10440-10458 doi:10.1039/d3ra00887h